Cannabinoid

Cannabinoids are a group of terpenophenolic compounds present in Cannabis (''Cannabis sativa'') and occur naturally in the nervous and immune systems of animals.

What are Cannabinoids?

Cannabinoids are naturally occurring compounds found in the Cannabis sativa plant. Of over 480 different compounds present in the plant, only around 66 are termed cannabinoids.

Synthetic and Patented Cannabinoids

The Immunological Effects of Cannabinoids

Crystal Structure of the Human Cannabinoid Receptor CB2

Pharmacology of Cannabinoid Receptors

A Failed Cannabis Hair Test - How Topical Application Results in Cannabinoid Incorporation

Does CBD Oil Work for Arthritis Pain?

Latest Cannabinoid News and Research

Friends and social media drive teen vaping trends

Young people with friends who vape are 15 times more likely to use e-cigarettes, and more adolescents are turning to illicit cannabis products, University of Queensland research has found.

1 Jul 2025

Salk researchers create detailed genetic atlas of cannabis to date

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive cannabinoid THC (tetrahydrocannabinol), historically, cannabis has been a cornerstone of human civilization, providing seed oil, textiles, and food for more than 10,000 years.

29 May 2025

UQ's new research center aims to improve lives of people living with pain

One of the world's foremost pain experts has highlighted the risks of bypassing established processes for assessing the safety and effectiveness of medicines at the launch of a research center at the University of Queensland.

10 Apr 2025

ACP issues Best Practice Advice on cannabis for chronic pain management

The American College of Physicians (ACP) has issued Best Practice Advice for clinicians whose patients are considering or using cannabis or cannabinoids for management of chronic, noncancer pain.

4 Apr 2025

CB1R inhibition shows promise in protecting gut barrier from alcohol damage

Heavy alcohol consumption is a leading cause of gastrointestinal diseases, with binge drinking linked to increased intestinal permeability-a condition commonly known as "leaky gut."

19 Mar 2025

UN Commission on Narcotic Drugs places six substances under international control following WHO recommendations

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under international control.

14 Mar 2025

Maternal cannabis use linked to increased risk of behavioral problems in children

Children exposed to their mother's cannabis use during pregnancy and after birth are three times more likely to develop behavioral problems, new Curtin University research has found.

6 Mar 2025

New drug VIP36 shows promise in treating pain without harmful side effects

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.

5 Mar 2025

The Future of CBD research, marketing, and regulation

In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD.

From Atlantia Clinical Trials 28 Feb 2025

Study reveals role of CB1 receptors in resilience to chronic stress

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience?

27 Feb 2025

Research highlights burden of cannabinoid hyperemesis syndrome

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome.

20 Feb 2025

Study shows long-term cannabis use disrupts critical brain processes

Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working memory tasks, while recent use may cause temporary cognitive impairments.

28 Jan 2025

Global cannabis boom brings unexpected cardiovascular risks to light

This review examines the cardiovascular risks associated with cannabis, revealing its potential to cause severe heart health issues and inform public policy.

27 Jan 2025

Study identifies potential pathway to improve memory in neurodegenerative diseases

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new therapies that improve memory in cases of cognitive impairment in neurodegenerative diseases such as Alzheimer's and Parkinson's.

16 Jan 2025

Study uncovers mechanism for cognitive improvement in dementia

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works

15 Jan 2025

High-fat diet linked to impulsive behaviors and brain changes

Researchers examines how a high-fat diet modifies inhibitory control.

14 Jan 2025

Could camembert cheese hold the key to better memory?

Myristamide enhances cognitive function and BDNF in mice, indicating Camembert cheese's potential in combating cognitive decline and supporting brain health.

9 Jan 2025

Understanding the mechanisms behind alcohol-associated liver disease

A newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this condition.

19 Dec 2024

Pioneering study shows promising results for cognitive treatment in Down syndrome

The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with the molecule AEF0217, developed by the French biotech Aelis Farma, as well as its effectiveness in improving cognitive function in these people.

17 Dec 2024

Targeting brain enzyme may offer new treatment for obesity

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated hospital research center.

16 Dec 2024